Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone.

McGee MD.

J Clin Psychiatry. 1997 Jan;58(1):32-3. No abstract available.

PMID:
9055839
2.

Remission of self-mutilation in a patient with borderline personality during risperidone therapy.

Khouzam HR, Donnelly NJ.

J Nerv Ment Dis. 1997 May;185(5):348-9. No abstract available.

PMID:
9171814
3.

Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder.

Chengappa KN, Ebeling T, Kang JS, Levine J, Parepally H.

J Clin Psychiatry. 1999 Jul;60(7):477-84.

PMID:
10453803
4.

Low-dose olanzapine for self-mutilation behavior in patients with borderline personality disorder.

Hough DW.

J Clin Psychiatry. 2001 Apr;62(4):296-7. No abstract available.

PMID:
11379847
5.

[Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].

Schmahl C, Bohus M.

Nervenarzt. 2000 May;71(5):427. German. No abstract available.

PMID:
10846724
6.

[Borderline personality disorder, self-mutilation and suicide: literature review].

Oumaya M, Friedman S, Pham A, Abou Abdallah T, Guelfi JD, Rouillon F.

Encephale. 2008 Oct;34(5):452-8. doi: 10.1016/j.encep.2007.10.007. Epub 2008 Feb 20. Review. French.

PMID:
19068333
7.

Naltrexone treatment of self-injurious thoughts and behaviors.

Sonne S, Rubey R, Brady K, Malcolm R, Morris T.

J Nerv Ment Dis. 1996 Mar;184(3):192-5. No abstract available.

PMID:
8600226
8.

Vomiting as a manifestation of borderline personality disorder in primary care.

Johnson TM.

J Am Board Fam Pract. 1993 Jul-Aug;6(4):385-94.

PMID:
8352042
9.

Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.

Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, Limberger MF, Böhme R, Schmahl CG.

J Clin Psychiatry. 1999 Sep;60(9):598-603.

PMID:
10520978
10.

Genetic, developmental and personality correlates of self-mutilation in depressed patients.

Joyce PR, McKenzie JM, Mulder RT, Luty SE, Sullivan PF, Miller AL, Kennedy MA.

Aust N Z J Psychiatry. 2006 Mar;40(3):225-9.

PMID:
16476149
11.

Recurrent suicide attempts, self-mutilation, and binge/purge behavior: a case report.

Schinagle M.

Harv Rev Psychiatry. 2002 Nov-Dec;10(6):353-63. No abstract available.

PMID:
12485981
12.

Female genital self-mutilation: case reports and literature review.

Wise TN, Dietrich AM, Segall E.

J Sex Marital Ther. 1989 Winter;15(4):269-74. Review.

PMID:
2693747
13.

[Treatment of dissociative symptoms in borderline patients with naltrexone].

Schmahl C, Stiglmayr C, Böhme R, Bohus M.

Nervenarzt. 1999 Mar;70(3):262-4. German.

PMID:
10231814
14.

Venesection as a rare form of self-mutilation.

Margo GM, Newman JS.

Am J Psychother. 1989 Jul;43(3):427-32.

PMID:
2817153
15.

[Self-mutilation from a forensic medicine viewpoint].

Zinka B, Rauch E.

Hautarzt. 2007 Apr;58(4):328-34. Review. German.

PMID:
17048021
16.

[Patients with a borderline disorder in the health care system].

van Meekeren E, Rooijumans HG.

Ned Tijdschr Geneeskd. 1996 Dec 7;140(49):2437-9. Dutch. No abstract available.

PMID:
8999341
17.
18.

Chronic suicidality and borderline personality.

Sansone RA.

J Pers Disord. 2004 Jun;18(3):215-25. Review.

PMID:
15237042
19.

Naltrexone for treatment of self-injury.

Lienemann J, Walker F.

Am J Psychiatry. 1989 Dec;146(12):1639-40. No abstract available.

PMID:
2589564
20.

Oxcarbazepine for self-mutilating bulimic patients.

Cordás TA, Tavares H, Calderoni DM, Stump GV, Ribeiro RB.

Int J Neuropsychopharmacol. 2006 Dec;9(6):769-71. Epub 2006 Aug 8. No abstract available.

PMID:
16893478
Items per page

Supplemental Content

Write to the Help Desk